Internal link ProQR Announces Results for the Fourth Quarter and Full Year 2017 and Provides Business Update February 28, 2018 at 12:00 PM UTC
Internal link ProQR Supports Rare Disease Day 2018 and Honors Henri A. Termeer February 27, 2018 at 12:00 PM UTC
Internal link Foundation Fighting Blindness will provide up to $7.5 million in funding to develop ProQR’s candidate QR-421a for Usher syndrome type 2A February 12, 2018 at 12:00 PM UTC
Internal link ProQR to Present at Upcoming Scientific Meeting and Investor Conference February 06, 2018 at 12:00 PM UTC
Internal link ProQR and Galapagos Announce Research Collaboration on Fibrosis Targets Using ProQR’s Axiomer® technology January 08, 2018 at 12:00 PM UTC
Internal link ProQR Therapeutics Announces Results for the Third Quarter of 2014 November 24, 2014 at 12:00 PM UTC
Internal link ProQR Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares September 23, 2014 at 05:37 PM UTC